Chilton Capital Management LLC purchased a new position in shares of Cigna Group (NYSE:CI – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 91 shares of the health services provider’s stock, valued at approximately $30,000.
Other large investors have also bought and sold shares of the company. Modern Wealth Management LLC grew its holdings in Cigna Group by 91.3% during the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock worth $1,030,000 after acquiring an additional 1,494 shares during the period. Janney Montgomery Scott LLC grew its stake in shares of Cigna Group by 3.9% during the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock worth $11,882,000 after purchasing an additional 1,357 shares during the period. Acadian Asset Management LLC increased its holdings in Cigna Group by 277.5% in the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock valued at $2,718,000 after purchasing an additional 6,082 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Cigna Group in the first quarter valued at about $431,000. Finally, Pzena Investment Management LLC boosted its holdings in Cigna Group by 9.7% during the second quarter. Pzena Investment Management LLC now owns 523,600 shares of the health services provider’s stock worth $173,092,000 after buying an additional 46,140 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.
Analysts Set New Price Targets
CI has been the subject of a number of recent analyst reports. Truist Financial set a $375.00 price target on Cigna Group in a research note on Tuesday, September 2nd. Guggenheim reiterated a “buy” rating and issued a $350.00 target price (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Barclays boosted their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research report on Friday. Finally, Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $369.89.
Check Out Our Latest Analysis on Cigna Group
Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than Cigna Group
- Insider Selling Explained: Can it Inform Your Investing Choices?
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What Are Dividend Achievers? An Introduction
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- The 3 Best Blue-Chip Stocks to Buy Now
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
